Point72 Asset Management, L.P. 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:02 pm Purchase | 2025-09-30 | 13G | Xilio Therapeutics, Inc. XLO | Point72 Asset Management, L.P. | 8,000,000 9.900% | 4,000,000 (+100.00%) | Filing |
| 2025-06-17 5:28 pm Purchase | 2025-06-05 | 13G | Xilio Therapeutics, Inc. XLO | Point72 Asset Management, L.P. | 4,000,000 7.200% | 4,000,000 (New Position) | Filing |